Answers are grounded in this paper and cite their sources.
Background Populations in Africa are ageing, and people living with HIV (PLHIV) are surviving longer largely due to antiretroviral therapy (ART). Tuberculosis (TB) has traditionally been considered a disease predominantly affecting young adults; however, the impact of shifting demographics on the age distribution of people living with TB (PWTB) is poorly understood. We sought to describe changes in age at TB diagnosis in Zimbabwe. Methods We conducted a rapid review and pooled multi-cohort analysis of individual participant data (IPD) using studies from Zimbabwe reporting age at TB diagnosis. We searched MEDLINE and Embase to 14th March 2025, screened studies for eligibility, and contacted authors to obtain IPD. Datasets were checked, cleaned and harmonised. We summarised age distributions across five-year periods to estimate crude median ages. We then fitted Bayesian regression models to estimate mean age at TB diagnosis over time, adjusting for sex, study and underlying population structure (using WorldPop data). Findings We analysed 12 datasets including 15,925 PWTB. On crude analysis the median age of PWTB increased from 32 years (interquartile range (IQR) 25.5–38.5) in 2000–2004 to 38 years (IQR 30.1–45.9) in 2020–2024. When modelled, with each calendar year between 2000 and 2024, age at TB diagnosis increased by 0.52 years of age (95% credible interval [CrI] 0.17–0.91). Interpretation Age at TB diagnosis in Zimbabwe increased between 2000 and 2024. TB programmes must adapt case-finding, clinical services and management for older adults considering multimorbidity, polypharmacy and frailty. TB notification data with greater granularity regarding age would improve understanding of this area. Funding JS is funded by the National Institute for Health and Care Research (NIHR) Academic Clinical Fellow scheme and the Elizabeth Blackwell Institute Global Health Fellowship. CLG is funded by an NIHR Global Health Research Professorship NIHR. PM is funded by Wellcome and an NIHR Global Health Research Professorship. CJC is funded by Wellcome.
No takes yet. Share an insight, caveat, or question.
Stanley et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: